|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Efficacy of RAD001 (Everolimus)
and Octreotide LAR in Advanced Low- to Intermediate-grade Neuroendocrine
Tumors: Results of a Phase II Study J Clin Oncol. 2008 Sep 10;26(26):4311-8.
PMID: 18779618 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |